Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance.
Lin H, Tison K, Du Y, Kirchhoff P, Kim C, Wang W, Yang H, Pitter M, Yu J, Liao P, Zhou J, Vatan L, Grove S, Wei S, Vigil T, Shah YM, Mortensen R, Kryczek I, Garmire L, Sivaccumar JP, Ramesh AK, Zhang N, An Z, Wang S, Zou W. Lin H, et al. Among authors: grove s. Cancer Cell. 2024 Dec 9;42(12):2032-2044.e6. doi: 10.1016/j.ccell.2024.10.010. Epub 2024 Nov 7. Cancer Cell. 2024. PMID: 39515327 Free article.
Evaluation of four interventions using behavioural economics insights to increase demand for voluntary medical male circumcision in South Africa through the MoyaApp: A quasi-experimental study.
Mistri P, Tomescu S, Bokolo S, De Nooy A, Pisa PT, Grove S, Schmucker L, Chetty-Makkan C, Long L, Buttenheim A, Maughan-Brown B. Mistri P, et al. Among authors: grove s. J Acquir Immune Defic Syndr. 2024 Aug 9;97(4):371-8. doi: 10.1097/QAI.0000000000003504. Online ahead of print. J Acquir Immune Defic Syndr. 2024. PMID: 39118223 Free PMC article.
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.
Yu J, Yan Y, Li S, Xu Y, Parolia A, Rizvi S, Wang W, Zhai Y, Xiao R, Li X, Liao P, Zhou J, Okla K, Lin H, Lin X, Grove S, Wei S, Vatan L, Hu J, Szumilo J, Kotarski J, Freeman ZT, Skala S, Wicha M, Cho KR, Chinnaiyan AM, Schon S, Wen F, Kryczek I, Wang S, Chen L, Zou W. Yu J, et al. Among authors: grove s. Cell. 2024 Aug 22;187(17):4713-4732.e19. doi: 10.1016/j.cell.2024.06.012. Epub 2024 Jul 4. Cell. 2024. PMID: 38968937 Free article.
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.
Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Choi JE, et al. Among authors: grove s. Nat Commun. 2024 Jun 28;15(1):5487. doi: 10.1038/s41467-024-48931-9. Nat Commun. 2024. PMID: 38942798 Free PMC article.
PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages.
Pitter MR, Kryczek I, Zhang H, Nagarsheth N, Xia H, Wu Z, Tian Y, Okla K, Liao P, Wang W, Zhou J, Li G, Lin H, Vatan L, Grove S, Wei S, Li Y, Zou W. Pitter MR, et al. Among authors: grove s. Cell Rep. 2024 Mar 26;43(3):113942. doi: 10.1016/j.celrep.2024.113942. Epub 2024 Mar 13. Cell Rep. 2024. PMID: 38489266 Free PMC article.
PIKfyve controls dendritic cell function and tumor immunity.
Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Choi JE, et al. Among authors: grove s. bioRxiv [Preprint]. 2024 Jul 1:2024.02.28.582543. doi: 10.1101/2024.02.28.582543. bioRxiv. 2024. Update in: Nat Commun. 2024 Jun 28;15(1):5487. doi: 10.1038/s41467-024-48931-9 PMID: 38464258 Free PMC article. Updated. Preprint.
136 results